AmpC β-Lactamases
Top Cited Papers
- 1 January 2009
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 22 (1), 161-182
- https://doi.org/10.1128/cmr.00036-08
Abstract
SUMMARY: AmpC β-lactamases are clinically important cephalosporinases encoded on the chromosomes of many of the Enterobacteriaceae and a few other organisms, where they mediate resistance to cephalothin, cefazolin, cefoxitin, most penicillins, and β-lactamase inhibitor-β-lactam combinations. In many bacteria, AmpC enzymes are inducible and can be expressed at high levels by mutation. Overexpression confers resistance to broad-spectrum cephalosporins including cefotaxime, ceftazidime, and ceftriaxone and is a problem especially in infections due to Enterobacter aerogenes and Enterobacter cloacae, where an isolate initially susceptible to these agents may become resistant upon therapy. Transmissible plasmids have acquired genes for AmpC enzymes, which consequently can now appear in bacteria lacking or poorly expressing a chromosomal blaAmpCgene, such as Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Resistance due to plasmid-mediated AmpC enzymes is less common than extended-spectrum β-lactamase production in most parts of the world but may be both harder to detect and broader in spectrum. AmpC enzymes encoded by both chromosomal and plasmid genes are also evolving to hydrolyze broad-spectrum cephalosporins more efficiently. Techniques to identify AmpC β-lactamase-producing isolates are available but are still evolving and are not yet optimized for the clinical laboratory, which probably now underestimates this resistance mechanism. Carbapenems can usually be used to treat infections due to AmpC-producing bacteria, but carbapenem resistance can arise in some organisms by mutations that reduce influx (outer membrane porin loss) or enhance efflux (efflux pump activation).Keywords
This publication has 369 references indexed in Scilit:
- Prevalence of AmpC and other β-lactamases in enterobacteria at a large urban university hospital in BrazilDiagnostic Microbiology and Infectious Disease, 2008
- In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care unitsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC β-lactamases–producing isolates of Escherichia coli and Klebsiella pneumoniaeDiagnostic Microbiology and Infectious Disease, 2005
- Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continentsDiagnostic Microbiology and Infectious Disease, 2005
- Characteristic analysis of the ampC gene encoding β-lactamase from Photobacterium phosphoreumBiochemical and Biophysical Research Communications, 2005
- Highly efficient renaturation of β‐lactamase isolated from moderately halophilic bacteriaFEBS Letters, 2004
- Sequence analysis of two chromosomally mediated inducible β-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinaseJournal of Antimicrobial Chemotherapy, 1995
- Interaction of clavulanate with class C β-lactamasesFEBS Letters, 1993
- Cloning of chromosomal β-lactamase genes from Yersinia enterocoliticaMicrobiology, 1991
- Clinical significance of beta-lactamase induction and stable derepression in gram-negative rodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987